Share
Market Research Report

GLOBAL VENDOR NEUTRAL ARCHIVE (VNA) MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Deployment ModelOn-Premise VNA · Cloud-Based VNA
  • By Vendor TypeIndependent Software Vendors (ISVs) · PACS Vendors · Infrastructure Vendors
  • By Imaging TypeRadiology VNAs · Cardiology VNAs · Pathology VNAs
  • By End UserHospitals · Diagnostic Imaging Centers · Ambulatory Care Centers · Research and Academic Institutes
  • Published In27 Apr 2026
  • Report CodeCMI6654
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Vendor Neutral Archive (VNA) Market, By Deployment Model
      • Global Vendor Neutral Archive (VNA) Market, By Vendor Type
      • Global Vendor Neutral Archive (VNA) Market, By Imaging Type
      • Global Vendor Neutral Archive (VNA) Market, By End User
      • Global Vendor Neutral Archive (VNA) Market, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Increasing adoption of cloud-based VNA solutions
      • Growing adoption of imaging equipment across healthcare facilities
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Service Offering Portfolio
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Pipeline Analysis
  4. Global Vendor Neutral Archive (VNA) Market, By Deployment Model, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • On-premise VNA
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Cloud-based VNA
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  5. Global Vendor Neutral Archive (VNA) Market, By Vendor Type, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Independent Software Vendors (ISVs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • PACS Vendors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Infrastructure Vendors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  6. Global Vendor Neutral Archive (VNA) Market, By Imaging Type, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Radiology VNAs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Cardiology VNAs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Pathology VNAs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  7. Global Vendor Neutral Archive (VNA) Market, By End User, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Diagnostic Imaging Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Ambulatory Care Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
    • Research and Academic Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  8. Global Vendor Neutral Archive

    (VNA) Market, By Region, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2021 – 2033
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Deployment Model, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Vendor Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Imaging Type, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033,(US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • Johnson & Johnson Private Limited
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • F. Hoffmann-La Roche Ltd.
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Baxter
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bayer AG
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Eli Lilly and Company
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sun Pharmaceutical Industries Ltd.
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Aurobindo Pharma
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Lupin
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Allergan
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AbbVie Inc.
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Abbott
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bausch Health Companies Inc.
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mylan N.V.
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AstraZeneca
      • Company Highlights
      • Deployment Model Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
  10. Section

    • Research Methodology
    • About us

*Browse 44 market data tables and 36 figures on “Global Vendor Neutral Archive (VNA) Market” - Global forecast to 2033